Lin, Y.-Z.; Shen, Y.-C.; Wu, W.-R.; Wang, W.-J.; Wang, Y.-L.; Lin, C.-Y.; Hung, M.-C.; Wang, S.-C.
Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. Int. J. Mol. Sci. 2021, 22, 6938.
https://doi.org/10.3390/ijms22136938
AMA Style
Lin Y-Z, Shen Y-C, Wu W-R, Wang W-J, Wang Y-L, Lin C-Y, Hung M-C, Wang S-C.
Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. International Journal of Molecular Sciences. 2021; 22(13):6938.
https://doi.org/10.3390/ijms22136938
Chicago/Turabian Style
Lin, You-Zhe, Yi-Chun Shen, Wan-Rong Wu, Wei-Jan Wang, Yuan-Liang Wang, Chen-Yuan Lin, Mien-Chie Hung, and Shao-Chun Wang.
2021. "Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles" International Journal of Molecular Sciences 22, no. 13: 6938.
https://doi.org/10.3390/ijms22136938
APA Style
Lin, Y.-Z., Shen, Y.-C., Wu, W.-R., Wang, W.-J., Wang, Y.-L., Lin, C.-Y., Hung, M.-C., & Wang, S.-C.
(2021). Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. International Journal of Molecular Sciences, 22(13), 6938.
https://doi.org/10.3390/ijms22136938
